Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

NUWE

Newellis (NUWE)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NUWE
DataOraFonteTitoloSimboloCompagnia
13/01/202514:00GlobeNewswire Inc.Nuwellis Adds Nationally Ranked Utah Hospital as New Pediatric Customer for Aquadex SmartFlow® TherapyNASDAQ:NUWENewellis Inc
19/12/202415:00GlobeNewswire Inc.Nuwellis Regains Compliance with Nasdaq Listing RequirementsNASDAQ:NUWENewellis Inc
20/11/202419:29Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:NUWENewellis Inc
11/11/202414:00GlobeNewswire Inc.Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent HighlightsNASDAQ:NUWENewellis Inc
11/11/202412:04IH Market NewsTesla Rises 5% Pre-Market After Surpassing $1T Market Value; U.S. Bans TSMC From Selling Advanced Chips to ChinaNASDAQ:NUWENewellis Inc
05/11/202415:28GlobeNewswire Inc.Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross ProceedsNASDAQ:NUWENewellis Inc
04/11/202414:30GlobeNewswire Inc.Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and MedicaidNASDAQ:NUWENewellis Inc
01/11/202421:15GlobeNewswire Inc.Nuwellis Announces Preliminary Results for Third Quarter of 2024NASDAQ:NUWENewellis Inc
31/10/202413:00GlobeNewswire Inc.Nuwellis Welcomes University of Iowa Health Care Stead Family Children’s Hospital as Newest Pediatric CustomerNASDAQ:NUWENewellis Inc
23/10/202422:15GlobeNewswire Inc.Nuwellis, Inc. To Report Third Quarter 2024 Financial Results on November 11, 2024NASDAQ:NUWENewellis Inc
25/09/202422:15GlobeNewswire Inc.Nuwellis to Present at the Third Annual ROTH Healthcare Opportunities ConferenceNASDAQ:NUWENewellis Inc
30/08/202422:11Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:NUWENewellis Inc
27/08/202415:00GlobeNewswire Inc.New Study Published in Current Problems in Cardiology Highlights Statistically Significant Reduction in Heart Failure Readmissions at 60 days when using the Aquadex Ultrafiltration TherapyNASDAQ:NUWENewellis Inc
26/08/202422:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
24/08/202403:31Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:NUWENewellis Inc
23/08/202415:00GlobeNewswire Inc.Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq RulesNASDAQ:NUWENewellis Inc
13/08/202423:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NUWENewellis Inc
13/08/202414:00GlobeNewswire Inc.Nuwellis, Inc. Announces Second Quarter 2024 Financial ResultsNASDAQ:NUWENewellis Inc
08/08/202415:00GlobeNewswire Inc.Nasdaq Panel Grants Nuwellis Continued Listing on the Nasdaq Stock Market, Subject to ConditionsNASDAQ:NUWENewellis Inc
26/07/202415:00GlobeNewswire Inc.Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s QUELIMMUNE™ Therapy at Cincinnati Children’sNASDAQ:NUWENewellis Inc
24/07/202414:02GlobeNewswire Inc.Nuwellis Announces Pricing of $2.0 Million Offering Priced At-The-Market Under Nasdaq RulesNASDAQ:NUWENewellis Inc
23/07/202422:10GlobeNewswire Inc.Nuwellis, Inc. To Report Second Quarter 2024 Financial Results on August 13, 2024NASDAQ:NUWENewellis Inc
17/07/202422:01Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:NUWENewellis Inc
17/07/202415:00GlobeNewswire Inc.Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children’sNASDAQ:NUWENewellis Inc
12/07/202414:30GlobeNewswire Inc.SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution PartnerNASDAQ:NUWENewellis Inc
10/07/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NUWENewellis Inc
09/07/202415:00GlobeNewswire Inc.New Evidence on Aquadex Ultrafiltration Therapy to be Presented at HFSA 2024 ConferenceNASDAQ:NUWENewellis Inc
26/06/202414:45GlobeNewswire Inc.Nuwellis Announces Reverse Stock SplitNASDAQ:NUWENewellis Inc
25/06/202415:00GlobeNewswire Inc.Nuwellis Secures New Patent for Innovative Pediatric Continuous Renal Replacement Therapy, Vivian™NASDAQ:NUWENewellis Inc
06/06/202415:00GlobeNewswire Inc.Nuwellis and DaVita Extend Supply and Collaboration Agreement Pilot PhaseNASDAQ:NUWENewellis Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NUWE
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network